Pediatric Endocrine Society https://validator.w3.org/feed/docs/rss2.html Home PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting Nutritional Tool Kit for Dyslipidemia Management PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting PES PMOS SIG Monthly Meeting Didactic: “Being an Ally that ACTS” Facilitator Training Webinar Case Practicum Workshop Infant with a Variation in Sex Characteristics (Ambiguous Genitalia) PES SIG State of the Art Series State of the Art – TREND SIG: Long-Acting Growth Hormone in Cancer Survivors: Risks, Benefits, and Clinical Practice PES PMOS SIG Monthly Meeting Patient Education Future Meetings Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17)  New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection  New Meds and Tech – Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes  June Fellow Spotlight – Cassie Gessling, MD  PES PMOS SIG Monthly Meeting New Investigator Award Mid-Career Investigator Award Judson J. Van Wyk Prize Mid-Career Investigator Award Application June 2026 President’s Letter Outstanding Mentor Award Application Drugs and Therapeutics Shortage Update: Estradiol Transdermal Patch   Clinician Award Shaping the Future of Care in Achondroplasia and Related Conditions Historical Tidbit – Then and Now: This Month in Endocrine History  Educator Award Turner Syndrome PES Research Surveys Health Systems Disparity Initiative Van Wyk Prize Application New Investigator Application 2026 Annual Meeting Session Recordings & Presentations Educator Award Application Clinician Award Application Ketotic Hypoglycemia Robert M. Blizzard, MD Lectureship 2027 Blizzard Lectureship Application Outstanding PES Mentor Award